Table 3. The dependent and Independent variables, experimental design matrix and results of D-optimal design.
| Run | Independent variables | Dependent variables | |||||
| A | B | C | Y1 | Y2 | Y3 | Y4 | |
|
SA/Phos
In range a |
NA/T
In range a |
Mixing
In range a |
Particle size
*
Minimize a |
Size SPAN |
Zeta potential
In range a |
%EE
Maximize a |
|
| 1 | 6.80 | 12.50 | bath | 0.469 | 0.59 | - 54.5 | 20.65 |
| 2 | 5.00 | 12.92 | stirrer | 0.63 | 3.61 | - 71.2 | 19.54 |
| 3 | 5.00 | 12.92 | stirrer | 0.662 | 3.65 | - 71.8 | 21.87 |
| 4 | 5.00 | 15.00 | probe | 0.389 | 1.59 | - 51.5 | 26.43 |
| 5 | 6.45 | 15.00 | stirrer | 0.529 | 0.64 | - 55.6 | 11.91 |
| 6 | 5.00 | 10.00 | bath | 0.07 | 0.73 | - 49.1 | 21.59 |
| 7 | 7.19 | 10.00 | stirrer | - | 2.33 | - 127.5 | 24.99 |
| 8 | 5.00 | 15.00 | probe | 0.435 | 0.55 | - 51.1 | 28.66 |
| 9 | 6.03 | 10.00 | stirrer | 0.57 | 2.31 | - 65.7 | 6.44 |
| 10 | 7.50 | 10.00 | probe | 1.976 | 3.76 | - 83.6 | 22.68 |
| 11 | 6.25 | 10.00 | bath | 0.495 | 0.54 | - 55.3 | 17.54 |
| 12 | 5.00 | 15.00 | bath | 0.577 | 1.35 | - 65.5 | 16.29 |
| 13 | 6.25 | 12.50 | probe | 0.088 | 0.74 | - 46.2 | 27.17 |
| 14 | 7.50 | 12.08 | stirrer | 0.608 | 4.19 | - 68.1 | 17.05 |
| 15 | 5.31 | 10.63 | probe | 0.068 | 0.69 | - 49.8 | 23.12 |
| 16 | 7.50 | 15.00 | probe | 0.112 | 0.69 | - 41.5 | 37.24 |
| 17 | 6.25 | 12.39 | stirrer | 0.162 | 4.21 | - 46.9 | 21.20 |
| 18 | 7.50 | 10.00 | bath | 6.701 | 0.64 | - 91.4 | 21.22 |
| 19 | 6.45 | 15.00 | stirrer | 0.494 | 2.19 | - 55.1 | 14.98 |
| 20 | 7.50 | 15.00 | probe | 0.095 | 0.75 | - 40.3 | 33.41 |
| 21 | 7.50 | 15.00 | bath | 0.231 | 0.37 | - 48.2 | 24.65 |
| 22 | 5.00 | 15.00 | bath | 0.547 | 0.83 | - 62.4 | 13.40 |
SA/Phos (stearic acid to Phospholipon®90G ratio); NA/T (nicotinamide to sodium taurocholate ratio); %EE=%Encapsulation efficiency.
* reported in µm
a Constrains